Patents by Inventor E. Lynette Wilson

E. Lynette Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6767737
    Abstract: A composition of substantially purified pluripotent stem cells are positive both for fibroblast growth factor receptor (FGFR) and a phenotype indicative of a primitive state, such as CD34+, CD34−lin−, Thy-1+, AC133+ or c-kit+. The state of being an embryonic stem cell is also a phenotype indicative of a primitive state. This population may be further defined by the subpopulations thereof which have another marker thereon indicative of endothelial cells, such as TIE-1+, TEK+, CD31+, VE-Cadherin+ or VEGFR+ or indicative of stromal cells, such as STRO-1+.
    Type: Grant
    Filed: August 31, 1999
    Date of Patent: July 27, 2004
    Assignee: New York University
    Inventors: E. Lynette Wilson, Patricia E. Burger